Verastem Inc. VSTM
$3.96
▲ +4.06% 24H
About
Verastem Inc. is a biopharmaceutical company that concentrates on developing and commercializing innovative cancer therapies. Its primary focus is on creating treatments targeting cancer cell survival and division pathways, specifically in hematologic malignancies and solid tumors. Key products in its pipeline include …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees78
TickerVSTM
Statistics
Market Cap$347.4M
Revenue (TTM)$30.9M
Net Income-$209.5M
Net Margin-677.6%
EPS$-3.02
P/E-1.35
P/S6.98
P/B5.35
EV/EBITDA-1.38
ROE-786.2%
Dividend Yield—
Price$3.96
Data: Twelve Data · Revenue = mcap / P/S